• OPEN AN ACCOUNT
Indian Indices
Sensex
78,009.25 -70.71
( -0.09%)
Global Indices
Nasdaq
53,854.87 63.60
(0.12%)
Dow Jones
7,820.53 51.03
(0.66%)
Hang Seng
68,711.00 402.41
(0.59%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.37 0.00
(0.00%)
EUR-INR
110.01 -0.06
(-0.05%)
GBP-INR
128.81 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
193.0629905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
53.47
15205.44
EPS(TTM)
Face Value()
Div & Yield %
27.18
1
0.52
 

Utkarsh Small Finance Bank reports standalone net loss of Rs 188.02 crore in the March 2026 quarter
May 11,2026
Net loss of Utkarsh Small Finance Bank reported to Rs 188.02 crore in the quarter ended March 2026 as against net profit of Rs 2.97 crore during the previous quarter ended March 2025. Total Operating Income declined 4.87% to Rs 836.75 crore in the quarter ended March 2026 as against Rs 879.62 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1150.98 crore in the year ended March 2026 as against net profit of Rs 23.70 crore during the previous year ended March 2025. Total Operating Income declined 10.26% to Rs 3378.78 crore in the year ended March 2026 as against Rs 3764.93 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Total Operating Income836.75879.62 -5 3378.783764.93 -10
OPM %13.5321.87 --1.0531.07 -
PBDT-232.0911.28 PL -1506.6227.65 PL
PBT-232.0911.28 PL -1506.6227.65 PL
NP-188.022.97 PL -1150.9823.70 PL